Instituto Universitario CEMIC - CABA

Instituto Universitario CEMIC - CABA
Valdenegro 4337, C1430EFA Cdad. Autónoma de Buenos Aires, Argentina
Select an option
Our team
Medical staff
Fernando Galanternik
Open studies
Bladder Cancer
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin - VOLGA - AstraZenecaSee more
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy